Patients with higher MRPL23 protein and mRNA levels had poorer survival outcomes, suggesting that MRPL23 may be a valuable marker for predicting prognosis in ccRCC. This evidence concerns the gene MRPL23 and nonpapillary renal cell carcinoma.